The Probiotic Parabacteroides johnsonii Ameliorates Metabolic Disorders Through Promoting BCAAs to BSCFAs Conversion
Advanced Science · 2025-10 · 12 (38)
DOI: 10.1002/advs.202502624 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.08.2025. Verfasst von Yimeng Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pukou Hospital of Chinese Medicine affiliated to China Pharmaceutical University, China Pharmaceutical University, 639 Longmian road, Nanjing, China. Hauptthemen laut MEDLINE: Probiotics, Metabolic Diseases, Amino Acids, Branched-Chain, Fatty Acids, Volatile. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Technologies Research and Development Program, Jiangsu Province Traditional Chinese Medicine Science and Technology Development Program.
Abstract (Originalsprache)
The gut bacterium Parabacteroides spp. is increasingly recognized for its therapeutic potential in treating metabolic disorders. However, the role of Parabacteroides johnsonii in metabolic disorders is never reported. Here, this study finds that the abundance of P. johnsonii in the feces is negatively correlated with the blood glucose and lipid levels of obese patients. Oral administration of live P. johnsonii improved the metabolic dysfunction in high fat diet (HFD)‐fed mice, accompanied by the alleviation of leaky gut and the systemic inflammation. P. johnsonii enhanced the catabolism of branched‐chain amino acids (BCAAs) to branched‐chain short‐chain fatty acids (BSCFAs) in gut. Particularly, the conversion of valine to isobutyrate is correlated to the symptoms of obese patients. Isobutyrate intervention mirrored the favorable effects of P. johnsonii on HFD‐fed mice. Isobutyrate increased H3K14 acetylation at Fgf1b promoters and activated its transcription through inhibition of HDAC3 in colon, thereby maintaining the intestinal barrier integrity. The natural product stachyose exerted anti‐obesity effects by enhancing the growth of P. johnsonii . These results offered insights into the mechanisms underlying the potential of P. johnsonii , isobutyrate, and stachyose in treating metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pukou Hospital of Chinese Medicine affiliated to China Pharmaceutical University, China Pharmaceutical University, 639 Longmian road, Nanjing, China.
- State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, 639 Longmian road, Nanjing, China.
- Department of Infectious Diseases, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Jie Yang
Förderung
- National Natural Science Foundation of China
- Key Technologies Research and Development Program
- Jiangsu Province Traditional Chinese Medicine Science and Technology Development Program
Zitieren
APA
Chen, Y., Jiang, S., Wang, H., Si, M., Wu, H., Liang, X., Yao, S., Zhang, Y., Wen, X., & Yang, J. (2025). The Probiotic Parabacteroides johnsonii Ameliorates Metabolic Disorders Through Promoting BCAAs to BSCFAs Conversion. Advanced Science, 12(38). https://doi.org/10.1002/advs.202502624
Vancouver
Chen Y, Jiang S, Wang H, Si M, Wu H, Liang X, et al. The Probiotic Parabacteroides johnsonii Ameliorates Metabolic Disorders Through Promoting BCAAs to BSCFAs Conversion. Advanced Science. 2025;12(38). doi:10.1002/advs.202502624
BibTeX
@article{Chen2025,
author = {Chen, Yimeng and Jiang, Shujun and Wang, Haolu and Si, Mengzhen and Wu, Haixia and Liang, Xinyi and Yao, Shenmeng and Zhang, Yanliang and Wen, Xiaodong and Yang, Jie},
title = {The Probiotic Parabacteroides johnsonii Ameliorates Metabolic Disorders Through Promoting BCAAs to BSCFAs Conversion},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {38},
doi = {10.1002/advs.202502624}
}
EUVIMED